GM-CSF or GM-CSF receptor ligands for use in the treatment of hematological malignancies in patients receiving allo HCT

摘要

This specification relates to the use of non agonist ligands, particularly antibodies.In particular, a non agonist ligand that specifically binds to GM-CSF receptors, including GM-CSF or CD116, CD131, or CD116 and CD131, treatment of leukemia in patients receiving allo HCT; Or for use in the treatment of other complications resulting from hematopoietic cell transplantation from immunologically nonidentical donors.No selection